pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 22·1 min read
save

Nabla executive Alex LeBrun discusses ‘world model’ AI as an alternative to large language models

Jul 22, 2026·read at STAT ↗Neutral

Brittany Trang of STAT’s AI Prognosis newsletter interviewed Alex LeBrun, the executive chairman of AI scribe company Nabla, to explore a concept called a “world model.”

LeBrun described a world model as a system that builds an internal representation of its environment, allowing it to predict outcomes without relying on the massive text datasets that power typical large language models.

The conversation also touched on growing concerns about privacy, noting that people are increasingly recording everyday interactions without consent, a trend highlighted by recent media coverage.

The interview is part of a subscriber‑only feature on STAT+, requiring a paid subscription to access the full content.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: What is a ‘world model’? Nabla’s Alex LeBrun explains”

read at STAT ↗
459 words · retrieved Jul 22
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
DisPATCH

related stories

  • Oct 6BioSpace 40 Under 40 winners make their mark on biopharmaBioSpace
  • Sep 24The FDA’s Overton era, and dispatches from ShanghaiSTAT
  • Sep 22New federal autism committee head has financial ties to leucovorinSTAT
  • Sep 18Who supports policies for ‘health equity’? It depends on how you’re askingSTAT
  • Aug 31STAT+: We’re reading about drug pricing deals, a new cancer therapy approval, and moreSTAT